Therapeutic Efficacy Of Extended Release Oxybutynin Chloride, And Immediate Release And Long Acting Tolterodine Tartrate In Children With Diurnal Urinary Incontinence
- 1 January 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (1) , 317-319
- https://doi.org/10.1016/s0022-5347(05)64115-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT StudyMayo Clinic Proceedings, 2001
- Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladderUrology, 2001
- TolterodineDrugs & Aging, 2001
- LONG-TERM EFFICACY OF SIMPLE BEHAVIORAL THERAPY FOR DAYTIME WETTING IN CHILDRENJournal of Urology, 2000
- Immediate‐Release Oxybutynin versus Tolterodine in Detrusor Overactivity: A Population AnalysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- THE OVERACTIVE BLADDER IN CHILDHOOD: LONG-TERM RESULTS WITH CONSERVATIVE MANAGEMENTJournal of Urology, 2000
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- EnuresisUrology, 1996
- Hinman syndrome: A vicious cycleUrology, 1993
- Micturition habits and incontinence in 7-year-old Swedish school entrantsEuropean Journal of Pediatrics, 1990